Prima Nexus Organises April 2015 Discussion Series Session on Diabetes and the Role of Glucagon
Dr Jibin Chi of Mercodia gave the plenary talk and Dr Thuan D. Bui of i-DNA Biotechnology also spoke at the Prima Nexus seminar on diabetes and glucagon at Hilton Hotel, KL Sentral, on 29 April 2015.
· Events & workshops
From the Prima Nexus archive: a look back at April 2015.
KUALA LUMPUR, 29 April 2015: Prima Nexus organised the April 2015 session of the PrimaNexus Discussion Series, a seminar on diabetes and the role of glucagon, held on 29 April 2015 at Hilton Hotel, KL Sentral, Kuala Lumpur. Dr Jibin Chi, Managing Director Asia Pacific of Mercodia, gave the plenary talk, and Dr Thuan D. Bui, founder and CEO of i-DNA Biotechnology, also spoke.
A seminar on diabetes and glucagon
The April 2015 session of the PrimaNexus Discussion Series looked at diabetes and the role of glucagon. It was held on 29 April 2015 in a meeting room at Hilton Hotel, KL Sentral, Kuala Lumpur, with participants seated at long tables facing the screen.
The two partner companies, Mercodia and i-DNA Biotechnology, each provided a speaker, and the certificate of attendance given to participants names both.
The speakers
Dr Jibin Chi, Managing Director Asia Pacific of Mercodia, gave the plenary talk. He trained in medicine at the Medical University of China, and his career includes work with pharmaceutical, biotech and medical device companies in Australia, Europe and the USA. He has been continuously involved in the development of diabetes-related technology.
Dr Thuan D. Bui, founder and CEO of i-DNA Biotechnology, also spoke. He holds a PhD in molecular biology from the University of London and was a research fellow at the University of Oxford and at the Institute of Molecular and Cell Biology, Singapore. In 2004 he started i-DNA Biotechnology in Singapore and Malaysia.
Prima Nexus's part
Prima Nexus organised the session, and participants received certificates of attendance, with a certificate of appreciation for the plenary speaker.
The two speakers came from different fields: Dr Chi from diabetes-related technology, and Dr Bui from molecular biology and DNA testing. Researchers who measure metabolic markers in their own studies can read about our ELISA and Luminex services, and later seminars and workshops are listed on our events page.
About Prima Nexus
Founded in 2014, Prima Nexus Sdn Bhd is a Malaysian research, scientific consulting and integrated research support company advancing scientific discovery and healthcare innovation. We provide end-to-end research solutions, from early-stage discovery and experimental design to cell-based studies, preclinical animal testing, clinical trials and commercialization. Our multidisciplinary expertise spans genomics, genetic applications, proteomics, molecular biology, stem cell research, bioinformatics and clinical research. Through strategic collaborations with universities, research institutions, industry and global technology partners, we connect scientific expertise and advanced technologies to accelerate research into real-world applications. Our collaborations have supported more than 150 papers in peer-reviewed journals and research teams at more than 40 institutions across Malaysia. More about Prima Nexus.
Media and partnership enquiries
Prima Nexus Sdn Bhd, Level 2, Mercu Aspire, 59200 KL Eco City, Kuala Lumpur, Malaysia. Email info@primanexus.com.my or WhatsApp 017-305 1076.
